Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
5
pubmed:dateCreated
2009-6-15
pubmed:databankReference
pubmed:abstractText
Human APOBEC3G (A3G) belongs to a family of polynucleotide cytidine deaminases. This family includes APOBEC1 and AID, which edit APOB mRNA and antibody gene DNA, respectively. A3G deaminates cytidines to uridines in single-strand DNA and inhibits the replication of human immunodeficiency virus-1, other retroviruses, and retrotransposons. Although the mechanism of A3G-catalyzed DNA deamination has been investigated genetically and biochemically, atomic details are just starting to emerge. Here, we compare the DNA cytidine deaminase activities and NMR structures of two A3G catalytic domain constructs. The longer A3G191-384 protein is considerably more active than the shorter A3G198-384 variant. The longer structure has an alpha1-helix (residues 201-206) that was not apparent in the shorter protein, and it contributes to catalytic activity through interactions with hydrophobic core structures (beta1, beta3, alpha5, and alpha6). Both A3G catalytic domain solution structures have a discontinuous beta2 region that is clearly different from the continuous beta2 strand of another family member, APOBEC2. In addition, the longer A3G191-384 structure revealed part of the N-terminal pseudo-catalytic domain, including the interdomain linker and some of the last alpha-helix. These structured residues (residues 191-196) enabled a novel full-length A3G model by providing physical overlap between the N-terminal pseudo-catalytic domain and the new C-terminal catalytic domain structure. Contrary to predictions, this structurally constrained model suggested that the two domains are tethered by structured residues and that the N- and C-terminal beta2 regions are too distant from each other to participate in this interaction.
pubmed:grant
pubmed:commentsCorrections
http://linkedlifedata.com/resource/pubmed/commentcorrection/19389408-10212987, http://linkedlifedata.com/resource/pubmed/commentcorrection/19389408-11142513, http://linkedlifedata.com/resource/pubmed/commentcorrection/19389408-11588250, http://linkedlifedata.com/resource/pubmed/commentcorrection/19389408-11863358, http://linkedlifedata.com/resource/pubmed/commentcorrection/19389408-11948792, http://linkedlifedata.com/resource/pubmed/commentcorrection/19389408-12051947, http://linkedlifedata.com/resource/pubmed/commentcorrection/19389408-12453430, http://linkedlifedata.com/resource/pubmed/commentcorrection/19389408-12522306, http://linkedlifedata.com/resource/pubmed/commentcorrection/19389408-12683974, http://linkedlifedata.com/resource/pubmed/commentcorrection/19389408-12808466, http://linkedlifedata.com/resource/pubmed/commentcorrection/19389408-12970355, http://linkedlifedata.com/resource/pubmed/commentcorrection/19389408-15296757, http://linkedlifedata.com/resource/pubmed/commentcorrection/19389408-15496550, http://linkedlifedata.com/resource/pubmed/commentcorrection/19389408-15516966, http://linkedlifedata.com/resource/pubmed/commentcorrection/19389408-15647250, http://linkedlifedata.com/resource/pubmed/commentcorrection/19389408-15668174, http://linkedlifedata.com/resource/pubmed/commentcorrection/19389408-15721369, http://linkedlifedata.com/resource/pubmed/commentcorrection/19389408-15829920, http://linkedlifedata.com/resource/pubmed/commentcorrection/19389408-16648136, http://linkedlifedata.com/resource/pubmed/commentcorrection/19389408-16731938, http://linkedlifedata.com/resource/pubmed/commentcorrection/19389408-17079235, http://linkedlifedata.com/resource/pubmed/commentcorrection/19389408-17187054, http://linkedlifedata.com/resource/pubmed/commentcorrection/19389408-17440614, http://linkedlifedata.com/resource/pubmed/commentcorrection/19389408-18184715, http://linkedlifedata.com/resource/pubmed/commentcorrection/19389408-18288108, http://linkedlifedata.com/resource/pubmed/commentcorrection/19389408-18304004, http://linkedlifedata.com/resource/pubmed/commentcorrection/19389408-18541215, http://linkedlifedata.com/resource/pubmed/commentcorrection/19389408-18577210, http://linkedlifedata.com/resource/pubmed/commentcorrection/19389408-18675436, http://linkedlifedata.com/resource/pubmed/commentcorrection/19389408-18820687, http://linkedlifedata.com/resource/pubmed/commentcorrection/19389408-19153609, http://linkedlifedata.com/resource/pubmed/commentcorrection/19389408-2372549, http://linkedlifedata.com/resource/pubmed/commentcorrection/19389408-7599282, http://linkedlifedata.com/resource/pubmed/commentcorrection/19389408-7718553, http://linkedlifedata.com/resource/pubmed/commentcorrection/19389408-7812156, http://linkedlifedata.com/resource/pubmed/commentcorrection/19389408-8289286, http://linkedlifedata.com/resource/pubmed/commentcorrection/19389408-8520220, http://linkedlifedata.com/resource/pubmed/commentcorrection/19389408-8888595, http://linkedlifedata.com/resource/pubmed/commentcorrection/19389408-9188594
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
IM
pubmed:chemical
pubmed:status
MEDLINE
pubmed:month
Jun
pubmed:issn
1089-8638
pubmed:author
pubmed:issnType
Electronic
pubmed:day
26
pubmed:volume
389
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
819-32
pubmed:dateRevised
2011-1-19
pubmed:meshHeading
pubmed:year
2009
pubmed:articleTitle
An extended structure of the APOBEC3G catalytic domain suggests a unique holoenzyme model.
pubmed:affiliation
Department of Biochemistry, Molecular Biology, and Biophysics, University of Minnesota, Minneapolis, 55455, USA.
pubmed:publicationType
Journal Article, Research Support, U.S. Gov't, Non-P.H.S., Research Support, Non-U.S. Gov't
More...